{"url_path":"/sec/elox/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1035354/0001193125-26-345032-index.html","accession_number":"0001193125-26-345032","cik":"0001035354","ticker":"ELOX","issuer_name":"Eloxx Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1035354/0001193125-26-345032-index.html","primary_entity_key":"0001035354","primary_entity_name":"Eloxx Pharmaceuticals, Inc."},"word_count":81,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n\n  \n\nExhibit Description\n\n99.1\n  \n[Press release of Eloxx Pharmaceuticals, Inc.](d167833dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: August 11, 2026\n \nELOXX PHARMACEUTICALS, INC.\n\n \n\n \nBy:\n \n\n/s/ Sumit Aggarwal\n\n \n\n \nName:\n \nSumit Aggarwal\n\n \n\n \nTitle:\n \nPresident and Chief Executive Officer"}